Lyell Immunopharma Appoints David Shook as Chief Medical Officer and Mark Meltz as General Counsel
Position
General Counsel
Company
Lyell Immunopharma
South San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Lyell Immunopharma, Inc. announces the appointment of David Shook, MD as Chief Medical Officer and Mark Meltz, JD as General Counsel. These new hires are expected to enhance the company's clinical capabilities as it advances its CAR T-cell therapies.
Quick answer
Lyell Immunopharma Appoints David Shook as Chief Medical Officer and Mark Meltz as General Counsel (June 9, 2025). Lyell Immunopharma is based in South San Francisco, California, United States.
- Who is the new General Counsel at Lyell Immunopharma?
- Lyell Immunopharma named Mark Meltz General Counsel, announced June 9, 2025.
- What did Lyell Immunopharma announce on June 9, 2025?
- Lyell Immunopharma, Inc. announces the appointment of David Shook, MD as Chief Medical Officer and Mark Meltz, JD as General Counsel. These new hires are expected to enhance the company's clinical capabilities as it advances its CAR T-cell therapies.
- What does Lyell Immunopharma do?
- Lyell Immunopharma, Inc. is a clinical-stage biotechnology company specializing in next-generation cell therapies for cancer patients.
- Where is Lyell Immunopharma based?
- Lyell Immunopharma is based in South San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Cure Rare Disease (June 9, 2025), Beacon Therapeutics (June 9, 2025), FibroBiologics (June 9, 2025) and RxMP Therapeutics (June 9, 2025) also announced leadership changes within 45 days of Lyell Immunopharma.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Cure Rare Disease Appoints Keith Sutton as Chief Science Officer (June 9, 2025)
- Beacon Therapeutics Appoints Dr. Daniel Chung as Chief Medical Officer (June 9, 2025)
- FibroBiologics Appoints Jason D. Davis as Chief Financial Officer (June 9, 2025)
- RxMP Therapeutics Appoints Shawna Khouri as Chief Operating Officer (June 9, 2025)
- Abcuro Appoints Courtney Cupples as Chief Commercial Officer (June 9, 2025)
- Vivex Biologics Appoints Jon E. Block as Chief Clinical Officer (June 10, 2025)
Who to call at Lyell Immunopharma, and when
A new leader at Lyell Immunopharma brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Lyell Immunopharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lyell Immunopharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lyell Immunopharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lyell Immunopharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lyell Immunopharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.